Prenetics Global Limited (PRENW)
PRENW Stock Price Chart
Explore Prenetics Global Limited interactive price chart. Choose custom timeframes to analyze PRENW price movements and trends.
PRENW Company Profile
Discover essential business fundamentals and corporate details for Prenetics Global Limited (PRENW) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
16 Jul 2021
Employees
285.00
Website
https://www.prenetics.comCEO
Sheng Wu Yeung
Description
Prenetics Global Limited operates as an investment holding company specializing in diagnostics and genetic testing. Its core offerings include CircleDNA, a consumer genetic testing solution, and the Circle HealthPod, a rapid detection health monitoring system that enables users to perform point-of-care or at-home COVID-19 tests using nucleic acid amplification technology. The company's portfolio further comprises ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an accessible at-home blood testing kit; and Circle Medical, a diagnostic testing platform. Other products include Circle One, F1x, and Fem. Established in 2014, Prenetics Global Limited is headquartered in Quarry Bay, Hong Kong.
PRENW Financial Timeline
Browse a chronological timeline of Prenetics Global Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Sept 2026
EPS estimate is -$0.84, while revenue estimate is $49.85m.
Earnings released on 10 Jun 2026
EPS came in at -$1.36 falling short of the estimated -$1.02 by -33.77%, while revenue for the quarter reached $35.95m , missing expectations by -0.13%.
Earnings released on 18 Feb 2026
EPS came in at -$1.77 falling short of the estimated -$0.33 by -436.36%, while revenue for the quarter reached $36.60m , beating expectations by +9.47%.
Earnings released on 10 Nov 2025
EPS came in at -$0.53 surpassing the estimated -$0.55 by +3.07%, while revenue for the quarter reached $23.56m , missing expectations by -9.40%.
Earnings released on 12 Sept 2025
EPS came in at -$0.94 falling short of the estimated -$0.71 by -31.94%, while revenue for the quarter reached $17.68m , missing expectations by -18.53%.
Earnings released on 22 Aug 2025
EPS came in at -$0.80 , while revenue for the quarter reached $17.31m .
PRENW Stock Performance
Access detailed PRENW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
